NCT00893542View on ClinicalTrials.gov

Bioequivalency Study of Mycophenolate Mofetil 250 mg Capsules Under Fasted Conditions

NACompletedINTERVENTIONAL
Enrollment

37

Participants

Timeline

Start Date

November 30, 2005

Primary Completion Date

November 30, 2005

Study Completion Date

November 30, 2005

Conditions
Prophylaxis of Organ Rejection
Interventions
DRUG

Mycophenolate Mofetil

mycophenolate mofetil 250 mg capsule

Trial Locations (1)

78759

CEDRA Clinical Research, LLC, Austin

All Listed Sponsors
lead

Roxane Laboratories

INDUSTRY

NCT00893542 - Bioequivalency Study of Mycophenolate Mofetil 250 mg Capsules Under Fasted Conditions | Biotech Hunter | Biotech Hunter